Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-cysteine (Acetium) for Migraine Prevention
NCT02315833Completed
- Sponsor
- Biohit Oyj
- Start
- Dec 2013
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Randomised, triple-blind trial in migraine comparing Acetium with Placebo (2 arms). Primary endpoint: Number of migraine attacks at 1 month. Started Dec 2013; status: completed.
02
Drugs
Acetium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02315833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315833.